Current Edition

clinical trials

Clinical Trials – Somewhere Between Tradition and Digital Modernity – A Wakeup Call

In the minds of young companies from the pharmaceutical or medical device sector, clinical trials lie somewhere in the future and are at best perceived …

Continue Reading →
agitation

Bionomics begins phase II clinical trial of drug for treating agitation

Bionomics will recruit about 40 elderly patients in specialist geriatric hospital wards across Australia. Bionomics Ltd (ASX:BNO) has commenced a phase II clinical trial of …

Continue Reading →
cancer

BerGenBio Meets First Efficacy Endpoint in Phase II Trial With Selective AXL Inhibitor BGB324 (bemcentinib) in NSCLC

BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective Axl kinase inhibitors as a potential cornerstone of combination cancer therapy, announces that the first …

Continue Reading →
clinical trial

Bevacizumab leads clinical trial activity for monoclonal antibodies, says GlobalData

When tracking clinical trial activity across the world, GlobalData, a leading data and analytics company, identified 5,273 industry monoclonal antibodies (mAb) clinical trials with a …

Continue Reading →
cancer

SOTIO Broadens Its Phase II Clinical Trial Program in Ovarian Cancer

SOTIO, a biotechnology company owned by the PPF Group, today announced the enrollment of the first patient to a Phase II study testing DCVAC/OvCa in combination …

Continue Reading →